Displaying results 1 - 10 / 10
results / page
What information about granted funding does the service contain?
Granted funding
Funder
Recipient
Starting year
Nanoscale architecture of hepatic neutral lipid flux in the ERResearch Council of FinlandHelsingin yliopisto2025Novel Effect biomarkers for MEtabolic disruptorS: evidence on health Impacts to answer science and policy needSEuropean UnionUniversity of Oulu; University of Eastern Finland; Tampere University2024Chlamydia pneumoniae and Its Structural Components in Finnish Donated Blood and Blood ProductsKAUTE-säätiöTheresa-Maria Kaudela2024Unraveling the etiology of congenital heart defects – The role of maternal genetics and cardiovascular disease as a risk factorEuropean UnionUniversity of Helsinki2023Novel circular RNAs for the treatment of atherosclerosisResearch Council of FinlandItä-Suomen yliopisto2022Next generation advanced RNA inhibition therapy to treat cardiometabolic diseaseEuropean UnionTampere University2022Residual cardiovascular risk: Identification of high-risk individualsResearch Council of FinlandJenny ja Antti Wihurin rahasto2020Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseasesEuropean UnionUniversity of Oulu; University of Eastern Finland2020Macrophage phenotypic polarization during atherogenesis in disease-associated tissuesResearch Council of FinlandItä-Suomen yliopisto2020Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathwaysEuropean UnionUniversity of Oulu; University of Eastern Finland2019
Nanoscale architecture of hepatic neutral lipid flux in the ER
2025
Novel Effect biomarkers for MEtabolic disruptorS: evidence on health Impacts to answer science and policy needS
2024
Chlamydia pneumoniae and Its Structural Components in Finnish Donated Blood and Blood Products
2024
Unraveling the etiology of congenital heart defects – The role of maternal genetics and cardiovascular disease as a risk factor
2023
Novel circular RNAs for the treatment of atherosclerosis
2022
Next generation advanced RNA inhibition therapy to treat cardiometabolic disease
2022
Residual cardiovascular risk: Identification of high-risk individuals
2020
Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases
2020
Macrophage phenotypic polarization during atherogenesis in disease-associated tissues
2020
Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways
2019